| Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis C Elliott, M Lindner, A Arthur, K Brennan, S Jarius, J Hussey, A Chan, ... Brain 135 (6), 1819-1833, 2012 | 176 | 2012 |
| Amyloid β synaptotoxicity is Wnt-PCP dependent and blocked by fasudil KJ Sellers, C Elliott, J Jackson, A Ghosh, E Ribe, AI Rojo, ... Alzheimer's & Dementia 14 (3), 306-317, 2018 | 97 | 2018 |
| A role for APP in Wnt signalling links synapse loss with β-amyloid production C Elliott, AI Rojo, E Ribe, M Broadstock, W Xia, P Morin, M Semenov, ... Translational psychiatry 8 (1), 179, 2018 | 90 | 2018 |
| Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination F Al Nimer, C Elliott, J Bergman, M Khademi, AM Dring, S Aeinehband, ... Neuroimmunology & Neuroinflammation 3 (1), e191, 2016 | 78 | 2016 |
| Role of IL-33 and ST2 signalling pathway in multiple sclerosis: expression by oligodendrocytes and inhibition of myelination in central nervous system D Allan, KJ Fairlie-Clarke, C Elliott, C Schuh, SC Barnett, H Lassmann, ... Acta neuropathologica communications 4, 1-10, 2016 | 72 | 2016 |
| Fibroblast growth factor signalling in multiple sclerosis: inhibition of myelination and induction of pro-inflammatory environment by FGF9 M Lindner, K Thümmler, A Arthur, S Brunner, C Elliott, D McElroy, ... Brain 138 (7), 1875-1893, 2015 | 67 | 2015 |
| Specific inhibition of phosphodiesterase-4B results in anxiolysis and facilitates memory acquisition A McGirr, TV Lipina, HS Mun, J Georgiou, AH Al-Amri, E Ng, D Zhai, ... Neuropsychopharmacology 41 (4), 1080-1092, 2016 | 61 | 2016 |
| Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination H Mohan, A Friese, S Albrecht, M Krumbholz, CL Elliott, A Arthur, ... Acta neuropathologica communications 2, 1-18, 2014 | 47 | 2014 |
| Plasma REST: A novel candidate biomarker of Alzheimer’s disease is modified by psychological intervention in an at-risk population NJ Ashton, A Hye, CA Leckey, AR Jones, A Gardner, C Elliott, ... Translational psychiatry 7 (6), e1148-e1148, 2017 | 44 | 2017 |
| FBXW7 regulates DISC1 stability via the ubiquitin-proteosome system K Yalla, C Elliott, JP Day, J Findlay, S Barratt, ZA Hughes, L Wilson, ... Molecular psychiatry 23 (5), 1278-1286, 2018 | 36 | 2018 |
| Targeted disruption of the heat shock protein 20–phosphodiesterase 4D (PDE4D) interaction protects against pathological cardiac remodelling in a mouse model of hypertrophy TP Martin, MP Hortigon-Vinagre, JE Findlay, C Elliott, S Currie, GS Baillie FEBS Open bio 4, 923-927, 2014 | 35 | 2014 |
| Missense mutation in DISC1 C-terminal coiled-coil has GSK3β signaling and sex-dependent behavioral effects in mice J Dachtler, C Elliott, RJ Rodgers, GS Baillie, SJ Clapcote Scientific Reports 6 (1), 18748, 2016 | 34 | 2016 |
| Bridging integrator 1 protein loss in Alzheimer’s disease promotes synaptic tau accumulation and disrupts tau release EB Glennon, DHW Lau, RMC Gabriele, MF Taylor, C Troakes, ... Brain communications 2 (1), fcaa011, 2020 | 26 | 2020 |
| Non-genetic therapeutic approaches to Canavan disease RB Roscoe, C Elliott, A Zarros, GS Baillie Journal of the neurological sciences 366, 116-124, 2016 | 22 | 2016 |
| The activity of cAMP-phosphodiesterase 4D7 (PDE4D7) is regulated by protein kinase A-dependent phosphorylation within its unique N-terminus AM Byrne, C Elliott, R Hoffmann, GS Baillie FEBS letters 589 (6), 750-755, 2015 | 22 | 2015 |
| SUMOylation of DISC1: a potential role in neural progenitor proliferation in the developing cortex S Tankou, K Ishii, C Elliott, KC Yalla, JP Day, K Furukori, K Kubo, ... Molecular neuropsychiatry 2 (1), 20-27, 2016 | 6 | 2016 |
| Brain N-acetylaspartate accumulation in Canavan disease is not neurotoxic per se: the implications of the first gene replacement therapy study to demonstrate successful post … C Elliott, H Al-Humadi, R Gutierrez-Quintana, A Zarros Annals of Research Hospitals 2 (4), 2018 | 1 | 2018 |
